Pyxis Oncology (PYXS) Invested Capital: 2024-2025
Historic Invested Capital for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $68.8 million.
- Pyxis Oncology's Invested Capital fell 55.25% to $68.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.8 million, marking a year-over-year decrease of 55.25%. This contributed to the annual value of $120.8 million for FY2024, which is N/A change from last year.
- Latest data reveals that Pyxis Oncology reported Invested Capital of $68.8 million as of Q3 2025, which was down 21.52% from $87.6 million recorded in Q2 2025.
- Over the past 5 years, Pyxis Oncology's Invested Capital peaked at $184.2 million during Q1 2024, and registered a low of $68.8 million during Q3 2025.
- In the last 2 years, Pyxis Oncology's Invested Capital had a median value of $120.8 million in 2024 and averaged $126.8 million.
- Data for Pyxis Oncology's Invested Capital shows a maximum YoY crashed of 55.25% (in 2025) over the last 5 years.
- Over the past 2 years, Pyxis Oncology's Invested Capital (Quarterly) stood at $120.8 million in 2024, then tumbled by 55.25% to $68.8 million in 2025.
- Its last three reported values are $68.8 million in Q3 2025, $87.6 million for Q2 2025, and $103.1 million during Q1 2025.